Cited by 91Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsNeuroscience and Neuropharmacology Research

Forebrain microglia from wild-type but not adult 5xFAD mice prevent amyloid-β plaque formation in organotypic hippocampal slice cultures

Open access
Hellwig, Sabine, Masuch, Annette, Nestel, Sigrun, Katzmarski, Natalie, Meyer-Luehmann, Melanie, Biber, Knut·2015·Scientific Reports

Abstract

The role of microglia in amyloid-β (Aβ) deposition is controversial. In the present study, an organotypic hippocampal slice culture (OHSC) system with an in vivo-like microglial-neuronal environment was used to investigate the potential contribution of microglia to Aβ plaque formation. We found that microglia ingested Aβ, thereby preventing plaque formation in OHSCs. Conversely, Aβ deposits formed rapidly in microglia-free wild-type slices. The capacity to prevent Aβ plaque formation was absent in forebrain microglia from young adult but not juvenile 5xFamilial Alzheimer’s disease (FAD) mice. Since no loss of Aβ clearance capacity was observed in both wild-type and cerebellar microglia from 5xFAD animals, the high Aβ 1−42 burden in the forebrain of 5xFAD animals likely underlies the exhaustion of microglial Aβ clearance capacity. These data may therefore explain why Aβ plaque formation has never been described in wild-type mice and point to a beneficial role of microglia in AD pathology. We also describe a new method to study Aβ plaque formation in a cell culture setting.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep14624

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Microglia play a crucial role in clearing Aβ plaques in the brain during Alzheimer's disease progression.

    “Microglia play a crucial role in clearing Aβ plaques in the brain during AD progression (25, 26).”

    From Reducing microglial lipid load enhances β amyloid phagocytosis in an Alzheimer’s disease mouse model (2025) · cites this paper as [26]

    The Results section reports that microglia ingest and digest Aβ in organotypic hippocampal slice cultures, and the Discussion describes a beneficial role in clearing Aβ. The paper supports a role in limiting plaque formation in that model, but does not establish that microglia clear existing plaques in the brain during AD progression; its Abstract notes that microglial depletion did not affect plaque load in two in vivo mouse models. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Rapid pruning of damaged synapses near dystrophic neurites localized around plaques appears to be, at least initially, protective and may go awry later in disease progression.

    “Rapid pruning of damaged synapses near dystrophic neurites localized around plaques appears to be, at least initially, protective and may go awry later in disease progression as described before68.”

    From Transcriptional signature in microglia associated with Aβ plaque phagocytosis (2021) · cites this paper as [68]

    The Discussion (page unavailable) says microglia from young 5xFAD mice can initially prevent plaque formation, whereas those from older mice lose that ability. It attributes this protective effect to amyloid-β clearance, not rapid pruning of damaged synapses near plaque-associated dystrophic neurites; the specific mechanism in the claim is unsupported. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 29

  1. Gilbert B. J. The role of amyloid β in the pathogenesis of Alzheimer’s disease. J. Clin. Pathol. 66, 362– 366 (2013). 23526599
  2. Malm T. M., Jay T. R. & Landreth G. E. The Evolving Biology of Microglia in Alzheimer’s Disease. Neurother. J. Am. Soc. Exp. Neurother. (2014). doi: 10.1007/s13311-014-0316-8. PMC4322081 25404051 · DOI · Paper page
  3. Prokop S., Miller K. R. & Heppner F. L. Microglia actions in Alzheimer’s disease. Acta Neuropathol. (Berl.) 126, 461– 477 (2013). 24224195
  4. Fleisher-Berkovich S. et al. Distinct modulation of microglial amyloid β phagocytosis and migration by neuropeptides (i). J. Neuroinflammation 7, 61 (2010). 20937084 PMC2964654
  5. Fu H. et al. Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar Aβ by microglia. Glia 60, 993– 1003 (2012). 22438044 PMC3325361
  6. Griciuc A. et al. Alzheimer’s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 78, 631– 643 (2013). 23623698 PMC3706457
  7. Mandrekar S. et al. Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. J. Neurosci. Off. J. Soc. Neurosci. 29, 4252– 4262 (2009). PMC3034143 19339619
  8. Beutner C. et al. Engineered stem cell-derived microglia as therapeutic vehicle for experimental autoimmune encephalomyelitis. Gene Ther. 20, 797– 806 (2013). 23324824
  9. Biber K., Owens T. & Boddeke E. What is microglia neurotoxicity (Not)? Glia 62, 841– 854 (2014). 24590682
  10. Hickman S. E. et al. The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci. 16, 1896– 1905 (2013). 24162652 PMC3840123
  11. Varvel N. H. et al. Microglial repopulation model reveals a robust homeostatic process for replacing CNS myeloid cells. Proc. Natl. Acad. Sci. USA 109, 18150– 18155 (2012). 23071306 PMC3497743
  12. Bahr B. A. Long-term hippocampal slices: a model system for investigating synaptic mechanisms and pathologic processes. J. Neurosci. Res. 42, 294– 305 (1995). 8583497
  13. Stoppini L., Buchs P. A. & Muller D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 37, 173– 182 (1991). 1715499
  14. Mewes A., Franke H. & Singer D. Organotypic brain slice cultures of adult transgenic P301S mice–a model for tauopathy studies. PloS One 7, e45017 (2012). 22984603 PMC3439393
  15. Braithwaite S. P. et al. Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer’s disease. Neurobiol. Dis. 39, 311– 317 (2010). 20451607 PMC2910136
  16. Alberdi E. et al. Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors. Cell Calcium 47, 264– 272 (2010). 20061018
  17. Kane M. D. et al. Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice. J. Neurosci. Off. J. Soc. Neurosci. 20, 3606– 3611 (2000). PMC6772682 10804202
  18. Ji K., Akgul G., Wollmuth L. P. & Tsirka S. E. Microglia actively regulate the number of functional synapses. PloS One 8, e56293 (2013). 23393609 PMC3564799
  19. Sturchler-Pierrat C. et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA 94, 13287– 13292 (1997). 9371838 PMC24301
  20. Radde R. et al. Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep. 7, 940– 946 (2006). 16906128 PMC1559665
  21. Lee J.-H. et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141, 1146– 1158 (2010). 20541250 PMC3647462
  22. Pickford F. et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J. Clin. Invest. 118, 2190– 2199 (2008). 18497889 PMC2391284
  23. Orre M. et al. Isolation of glia from Alzheimer’s mice reveals inflammation and dysfunction. Neurobiol. Aging 35, 2746– 2760 (2014). 25002035
  24. Mosher K. I. & Wyss-Coray T. Microglial dysfunction in brain aging and Alzheimer’s disease. Biochem. Pharmacol. 88, 594– 604 (2014). 24445162 PMC3972294
  25. De Jong E. K. et al. Expression of CXCL4 in microglia in vitro and in vivo and its possible signaling through CXCR3. J. Neurochem. 105, 1726– 1736 (2008). 18248618
  26. De Haas A. H., Boddeke H. W. G. M., Brouwer N. & Biber K. Optimized isolation enables ex vivo analysis of microglia from various central nervous system regions. Glia 55, 1374– 1384 (2007). 17661344
  27. De Haas A. H., Boddeke H. W. G. M. & Biber K. Region-specific expression of immunoregulatory proteins on microglia in the healthy CNS. Glia 56, 888– 894 (2008). 18338796
  28. Van Weering H. R. J. et al. CXCL10/CXCR3 signaling in glia cells differentially affects NMDA-induced cell death in CA and DG neurons of the mouse hippocampus. Hippocampus 21, 220– 232 (2011). 20082289
  29. Sun A., Nguyen X. V. & Bing G. Comparative analysis of an improved thioflavin-s stain, Gallyas silver stain, and immunohistochemistry for neurofibrillary tangle demonstration on the same sections. J. Histochem. Cytochem. Off. J. Histochem. Soc. 50, 463– 472 (2002). 11897799

Cited by

Sorted by citations

Authors
Hellwig, S., Masuch, A., Nestel, S., Katzmarski, N., Meyer-Luehmann, M., & Biber, K.
Affiliations
  • University of Freiburg (DE)
  • University Medical Center Groningen (NL)
Corresponding author
Biber, Knut
Venue
Scientific Reports
Published
2015-09-29
Volume
5
Issue
1
Pages
14624-14624
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2397672509
Cited by
91
References
16
Citations by year
2026: 1 · 2025: 9 · 2024: 4 · 2023: 9 · 2022: 6 · 2021: 11 · 2020: 11 · 2019: 14 · 2018: 4 · 2017: 10 · 2016: 12
FWCI
6.38
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by)
  • FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
Funders
  • Deutsche Forschungsgemeinschaft (FOR1336)
  • Bundesministerium für Bildung und Forschung
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
microglia, amyloid-beta, Alzheimer's disease, 5xFAD mice, organotypic hippocampal slice cultures, microglial phagocytosis, amyloid-beta clearance, amyloid-beta 42
MeSH terms
Age Factors, Alzheimer Disease, Animals, Biological Transport, Disease Models, Animal, Female, Hippocampus, Male, Mice, Inbred C57BL, Mice, Transgenic, Microtomy, Peptide Fragments, Amyloid beta-Peptides, Prosencephalon, Microglia, Tissue Culture Techniques, Mice, Plaque, Amyloid, Disease Resistance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review